Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00440024 · ClinicalTrials.gov registry record · NA
The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid Tolerance
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00440024: Completed NA study, sponsored by University of Michigan.
NCT00440024 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00440024, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Sun-damaged skin, caused by chronic exposure to ultraviolet (UV) light, is characterized by features such as wrinkling, uneven skin color, roughness and brown spots. An effective treatment for sun-damage that is commonly prescribed is topical retinoic acid (RA). However, the major drawback of topical RA use has been frequently observed irritation characterized by redness, dry skin and severe itching. In this study, we examine whether a daily skin care regimen comprised of an ultra mild cleanser and an effective moisturizer can help improve tolerance to RA treatment.
Interventions
- DRUG Tazorac
- DRUG Dove Mild Cleanser
- DRUG Dove Facial Moisturizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-11 |
| Phase | NA |
What the finished NCT00440024 record still lists
NCT00440024 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Tazorac is the first listed.
NCT00440024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00440024 about?
NCT00440024 is a clinical study titled "The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid Tolerance". Sun-damaged skin, caused by chronic exposure to ultraviolet (UV) light, is characterized by features such as wrinkling, uneven skin color, roughness and brown spots. An effective treatment for sun-damage that is commonly prescribed is topical retinoic acid (RA). However, the major drawback of topica...
What is the current status of trial NCT00440024?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-02. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00440024?
The interventions under investigation include: Tazorac (DRUG), Dove Mild Cleanser (DRUG), Dove Facial Moisturizer (DRUG).
Who is sponsoring clinical trial NCT00440024?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00440024's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia